Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Politicians', bureaucrats' drug plans deemed too costly for public formularies

Wayne Kondro
CMAJ March 13, 2007 176 (6) 755; DOI: https://doi.org/10.1503/cmaj.070211
Wayne Kondro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
  • © 2007 Canadian Medical Association or its licensors

Call a spade a spade, says Lillian Morgenthau, president of Canada's Association for the Fifty Plus (CARP).

Politicians and bureaucrats whose taxpayer-funded drug plans include medications that they've deemed too expensive for the formularies of public plans for seniors, Aboriginals, veterans and soldiers are being nothing short of “hypocritical,” Morgenthau told CMAJ.

A study conducted for CARP, a non-profit advocacy group, by consultants Wyatt Health Management, a for-profit provider of consulting services in market access and reimbursement, found that public drug plans for federal, Ontario and BC politicians and civil servants was far more expansive than other public plans administered by governments.

“It's unbelievable,” says Morgenthau. “There's no necessity for this double standard, especially when we're paying for it. If it's too costly to include us, then it's too costly to include them.”

Wyatt assessed the status of the 73 drugs that have been approved by Health Canada and submitted to the Common Drug Review, an independent, intergovernmental body that recommends whether a medication should be included in federal and provincial formularies (except in Quebec).

With the exception of 2 drugs that manufacturers haven't yet made available in Canada, 71 of the 73 drugs were automatically included in benefit plans of politicians and civil servants the moment they received Health Canada approval for sale in Canada.

The Common Drug Review, which assesses the cost-effectiveness of new drugs, recommended that 28 of the 73 be made available in the non-political plans. All but 1 (which isn't yet sold in Canada) are in the veteran's plan but only 20 are in the soldier's plans, while only 15 are reimbursed by the Ontario, BC and federal Aboriginal drug benefits plans.

Of the 26 drugs the Common Drug Review recommended not be listed, 1 is unavailable for sale, and 3 are included in the soldiers and Aboriginals plans. The BC plan covers 2 and Ontario 1. The remaining 19 drugs in the list of 73 are still under CDR review.

Wyatt Health Management founder and managing director George Wyatt argues it's disingenuous for administrators to say the discrepancies are incidental because an individual can seek “special authorization” to have a drug covered. “Those mechanisms can be onerous and it depends on the motivation of the physician,” Wyatt says. “Sometimes it depends on the physician's writing skills. The people in the public sector don't have to exactly go through the same hoops.”

It's also inefficient, Wyatt adds. “We have a physician shortage in this country and physicians only have so many hours. If they have to spend more time on administration, it's not a good use of resources.”

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 176 (6)
CMAJ
Vol. 176, Issue 6
13 Mar 2007
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Politicians', bureaucrats' drug plans deemed too costly for public formularies
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Politicians', bureaucrats' drug plans deemed too costly for public formularies
Wayne Kondro
CMAJ Mar 2007, 176 (6) 755; DOI: 10.1503/cmaj.070211

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Politicians', bureaucrats' drug plans deemed too costly for public formularies
Wayne Kondro
CMAJ Mar 2007, 176 (6) 755; DOI: 10.1503/cmaj.070211
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feds update immunization advice with Moderna vaccine approval
  • Canada will have three-digit suicide prevention hotline by 2023
  • Trudeau promises to boost federal health transfers when the pandemic is over
Show more News

Similar Articles

Collections

  • Topics
    • Pharmacology & toxicology
    • Drug regulation

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire